Show simple item record

dc.contributor.authorJohnston, Aen_US
dc.contributor.authorHolt, DWen_US
dc.date.accessioned2016-06-01T15:16:01Z
dc.date.available2013-11-01en_US
dc.date.issued2014-08en_US
dc.date.submitted2016-05-31T14:57:00.434Z
dc.identifier.issn0306-5251en_US
dc.identifier.urihttp://qmro.qmul.ac.uk/xmlui/handle/123456789/12629
dc.format.extent218 - 243en_US
dc.language.isoenen_US
dc.relation.ispartofBRITISH JOURNAL OF CLINICAL PHARMACOLOGYen_US
dc.rightsCC-BY-NC-ND
dc.subjectdrug qualityen_US
dc.subjectfalsificationen_US
dc.subjectinspectionen_US
dc.subjectregulationen_US
dc.subjectsubstandarden_US
dc.titleSubstandard drugs: a potential crisis for public healthen_US
dc.typeArticle
dc.rights.holder© 2013 The Authors.
dc.identifier.doi10.1111/bcp.12298en_US
pubs.author-urlhttp://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000340244800003&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=612ae0d773dcbdba3046f6df545e9f6aen_US
pubs.issue2en_US
pubs.notesNot knownen_US
pubs.publication-statusPublisheden_US
pubs.volume78en_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record